MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

Search

Aurinia Pharmaceuticals Inc

Închisă

SectorSănătate

7.46 -1.45

Rezumat

Modificarea prețului

24h

Curent

Minim

7.35

Maxim

7.6

Indicatori cheie

By Trading Economics

Venit

22M

23M

Vânzări

2.6M

62M

P/E

Medie Sector

31.37

40.527

EPS

0.16

Marjă de profit

37.371

Angajați

130

EBITDA

15M

22M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+28.46% upside

Dividende

By Dow Jones

Următoarele câștiguri

31 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

16M

1.1B

Deschiderea anterioară

8.91

Închiderea anterioară

7.46

Sentimentul știrilor

By Acuity

77%

23%

348 / 375 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Aurinia Pharmaceuticals Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 iul. 2025, 15:29 UTC

Principalele dinamici ale pieței

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

7 iul. 2025, 23:44 UTC

Market Talk

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

7 iul. 2025, 23:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 iul. 2025, 23:41 UTC

Market Talk

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

7 iul. 2025, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

7 iul. 2025, 23:19 UTC

Market Talk

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

7 iul. 2025, 22:20 UTC

Market Talk

Global Equities Roundup: Market Talk

7 iul. 2025, 22:20 UTC

Market Talk

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

7 iul. 2025, 21:34 UTC

Achiziții, Fuziuni, Preluări

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

7 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

7 iul. 2025, 20:45 UTC

Achiziții, Fuziuni, Preluări

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 iul. 2025, 20:16 UTC

Market Talk

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

7 iul. 2025, 19:37 UTC

Market Talk

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

7 iul. 2025, 19:12 UTC

Market Talk

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

7 iul. 2025, 18:33 UTC

Market Talk

Gold Flat as Investors Assess Market Direction -- Market Talk

7 iul. 2025, 18:27 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

7 iul. 2025, 16:53 UTC

Câștiguri

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

7 iul. 2025, 16:30 UTC

Market Talk

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

7 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7 iul. 2025, 16:05 UTC

Achiziții, Fuziuni, Preluări

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 iul. 2025, 15:41 UTC

Market Talk

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

7 iul. 2025, 15:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

7 iul. 2025, 15:40 UTC

Market Talk

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

7 iul. 2025, 15:30 UTC

Market Talk

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

7 iul. 2025, 15:18 UTC

Market Talk

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

7 iul. 2025, 15:14 UTC

Achiziții, Fuziuni, Preluări

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

7 iul. 2025, 15:00 UTC

Achiziții, Fuziuni, Preluări

GSK Completes Acquisition of Efimosfermin

7 iul. 2025, 14:52 UTC

Market Talk

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

7 iul. 2025, 14:51 UTC

Market Talk

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

7 iul. 2025, 14:45 UTC

Market Talk

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Comparație

Modificare preț

Aurinia Pharmaceuticals Inc Așteptări

Obiectiv de preț

By TipRanks

28.46% sus

Prognoză pe 12 luni

Medie 9.75 USD  28.46%

Maxim 11 USD

Minim 8 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruAurinia Pharmaceuticals Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

4

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

8.1 / 8.21Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Bullish Evidence

Sentiment

By Acuity

348 / 375 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.